Shu-Yuan Hu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Transcription Factor

Papillary Thyroid

Top Venues

Cancer research

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Min-Ying Huang, Shu-Yuan Hu, Jia Dong, Ling Deng, Lisa Andriani, Xiao-Yan Ma, Yin-Ling Zhang, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer. Cancer research 84 (16) (2024)
Min-Ying Huang, Shu-Yuan Hu, Jia Dong, Ling Deng, Lisa Andriani, Xiao-Yan Ma, Yin-Ling Zhang, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer. Cancer research (2024)
Ling Deng, Li Liao, Yin-Ling Zhang, Shao-Ying Yang, Shu-Yuan Hu, Lisa Andriani, Yun-Xiao Ling, Xiao-Yan Ma, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1. Science advances 10 (14) (2024)
Ling Deng, Li Liao, Yin-Ling Zhang, Shao-Ying Yang, Shu-Yuan Hu, Lisa Andriani, Yun-Xiao Ling, Xiao-Yan Ma, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1. Science advances 10 (14) (2024)
Ling Deng, Li Liao, Yin-Ling Zhang, Shao-Ying Yang, Shu-Yuan Hu, Lisa Andriani, Yun-Xiao Ling, Xiao-Yan Ma, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1. Science advances 10 (14) (2024)
Min-Ying Huang, Shu-Yuan Hu, Jia Dong, Ling Deng, Lisa Andriani, Xiao-Yan Ma, Yin-Ling Zhang, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer. Cancer research 84 (16) (2024)
Li Liao, Yin-Ling Zhang, Ling Deng, Chao Chen, Xiao-Yan Ma, Lisa Andriani, Shao-Ying Yang, Shu-Yuan Hu, Fang-Lin Zhang, Zhi-Ming Shao, Da-Qiang Li
Protein phosphatase 1 subunit PPP1R14B stabilizes STMN1 to promote progression and paclitaxel resistance in triple-negative breast cancer. Cancer research (2022)